Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: GKRichard / Re: My 2 cents on the R/S discussion

Not necessarily, as at $6, a much different pool of potential investors could buy. Furthermore, when you take into account this:



PERIOD ENDING 31-May-08 31-May-07 31-May-06
Net Tangible Assets $23,238 $20,133 $10,796


you are in a category of companies that is less typical of those who utilize the R/S to MAINTAIN their listing on the NAS or elsewhere, and that institutional investor pool MIGHT (provided that the guidance and visibility of repeatable consistent revenue growth is provided), just MIGHT be buying.

1
Jan 08, 2009 01:25PM
1
Jan 09, 2009 05:57AM
Share
New Message
Please login to post a reply